World's Best Scientists 2026 revealed!
Giovanni Martinelli

Giovanni Martinelli

Award Badge
Medicine
Italy
2023

D-Index & Metrics

Medicine

D-Index
132
Citations
72651
World Ranking
2298
National Ranking
49

Giovanni Martinelli publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Giovanni Martinelli sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 1,840 publications — 100th percentile

100% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Giovanni Martinelli D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Giovanni Martinelli sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 132 D-Index — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2023 - Research.com Medicine in Italy Leader Award

Overview

Giovanni Martinelli is affiliated with the University of Bologna in Italy. Their research primarily focuses on medicine and biochemistry, genetics, and molecular biology, with specialized work in hematology, molecular biology, oncology, genetics, and public health, environmental and occupational health.

The main topics of their research include:

  • Acute Myeloid Leukemia Research
  • Chronic Myeloid Leukemia Treatments
  • Acute Lymphoblastic Leukemia Research
  • CAR-T Cell Therapy Research
  • Multiple Myeloma Research and Treatments
  • Protein Degradation and Inhibitors
  • Chronic Lymphocytic Leukemia Research

Martinelli's body of work has been published frequently in several prominent journals. These publication venues include:

  • Blood
  • Frontiers in Oncology
  • Cancers
  • Panminerva Medica
  • Journal of Clinical Oncology

Their recent notable publications feature works such as:

  • "MDM2 inhibition: an important step forward in cancer therapy" (2020), published in Leukemia
  • "A WEE1 family business: regulation of mitosis, cancer progression, and therapeutic target" (2020), published in Journal of Hematology & Oncology
  • "Magnitude and Dynamics of the T-Cell Response to SARS-CoV-2 Infection at Both Individual and Population Levels" (2020), published in bioRxiv (Cold Spring Harbor Laboratory)
  • "Colour deconvolution: stain unmixing in histological imaging" (2020), published in Bioinformatics
  • "Mutant Isocitrate Dehydrogenase 1 Inhibitor Ivosidenib in Combination With Azacitidine for Newly Diagnosed Acute Myeloid Leukemia" (2020), published in Journal of Clinical Oncology

Their collaborative network includes frequent coauthors such as:

  • Claudio Cerchione
  • Giorgia Simonetti
  • Giovanni Marconi
  • Cristina Papayannidis
  • Antonio Curti

Martinelli's research contributions cover a broad spectrum of hematologic malignancies and molecular pathways, contributing to understanding leukemia pathophysiology and treatment options. Their work reflects ongoing involvement in cancer therapies, immune response dynamics, and histological analysis methods within the biomedical research community.

Best Publications

  • European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013

    Michele Baccarani;Michael W. Deininger;Gianantonio Rosti;Andreas Hochhaus

  • Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia.

    Hagop M. Kantarjian;Daniel J. DeAngelo;Matthias Stelljes;Giovanni Martinelli

  • Prevention of High-Dose Chemotherapy–Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition

    Daniela Cardinale;Alessandro Colombo;Maria T. Sandri;Giuseppina Lamantia

  • International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts

    Hervé Dombret;John F. Seymour;Aleksandra Butrym;Agnieszka Wierzbowska

  • Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results

    Timothy P Hughes;Michael W Deininger;Andreas Hochhaus;Susan Branford

  • Prognostic Value of Troponin I in Cardiac Risk Stratification of Cancer Patients Undergoing High-Dose Chemotherapy

    Daniela Cardinale;Maria T. Sandri;Alessandro Colombo;Nicola Colombo

  • Gilteritinib or chemotherapy for relapsed or refractory FLT3-mutated AML

    Alexander E. Perl;Giovanni Martinelli;Jorge E. Cortes;Andreas Neubauer

  • Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project

    Massimo Federico;Monica Bellei;Luigi Marcheselli;Stefano Luminari

  • The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts

    Camille Abboud;Ellin Berman;Adam Cohen

  • Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia.

    Giampaolo Bucaneve;Alessandra Micozzi;Francesco Menichetti;Pietro Martino

  • Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy

    Daniela Cardinale;Maria Teresa Sandri;Alessandro Martinoni;Alessio Tricca

  • Contribution of ABL Kinase Domain Mutations to Imatinib Resistance in Different Subsets of Philadelphia-Positive Patients: By the GIMEMA Working Party on Chronic Myeloid Leukemia

    Simona Soverini;Sabrina Colarossi;Alessandra Gnani;Gianantonio Rosti

  • Prolonged treatment with rituximab in patients with follicular lymphoma significantly increases event-free survival and response duration compared with the standard weekly × 4 schedule

    Michele Ghielmini;Shu Fang Hsu Schmitz;Sergio B. Cogliatti;Gabriella Pichert

  • Patterns of Outcome and Prognostic Factors in Primary Large-Cell Lymphoma of the Testis in a Survey by the International Extranodal Lymphoma Study Group

    E. Zucca;A. Conconi;T.I. Mughal;A.H. Sarris

  • Resting and activated endothelial cells are increased in the peripheral blood of cancer patients

    Patrizia Mancuso;Alessandra Burlini;Giancarlo Pruneri;Aron Goldhirsch

  • Very young women (<35 years) with operable breast cancer: features of disease at presentation

    M. Colleoni;N. Rotmensz;C. Robertson;L. Orlando

  • Nilotinib is effective in patients with chronic myeloid leukemia in chronic phase after imatinib resistance or intolerance: 24-month follow-up results

    Hagop M. Kantarjian;Francis J. Giles;Kapil N. Bhalla;Javier A. Pinilla-Ibarz

  • Dasatinib as first-line treatment for adult patients with Philadelphia chromosome–positive acute lymphoblastic leukemia

    Robin Foà;Antonella Vitale;Marco Vignetti;Giovanna Meloni

  • Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1–2 study

    Alexander E. Perl;Jessica K. Altman;Jorge Cortes;Catherine Smith

  • Bcr-Abl kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet

    Simona Soverini;Andreas Hochhaus;Franck E. Nicolini;Franz Gruber

Frequent Co-Authors

Michele Baccarani
Michele Baccarani University of Bologna
Michele Cavo
Michele Cavo University of Bologna
Giuseppe Saglio
Giuseppe Saglio University of Turin
Giancarlo Pruneri
Giancarlo Pruneri University of Milan
Sante Tura
Sante Tura University of Bologna
Jorge E. Cortes
Jorge E. Cortes Augusta University
Giorgina Specchia
Giorgina Specchia University of Bari Aldo Moro
Massimo Delledonne
Massimo Delledonne University of Verona
Emanuele Zucca
Emanuele Zucca Universita della Svizzera Italiana
Hagop M. Kantarjian
Hagop M. Kantarjian The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Medicine but seeking flexible or alternative educational opportunities, online degrees offer a wide range of career-focused options. The rise of online health administration programs makes it easier to develop essential leadership skills for healthcare settings, even while balancing other commitments.

If you are an RN looking to advance your clinical role, the rn to np bridge program provides a fast-track pathway to becoming a nurse practitioner. These programs are designed for working nurses who want to deepen their expertise and expand their career options.

For those focusing on preventative care and wellness, online nutrition degrees build foundational knowledge in health, diet, and chronic disease management—opening doors in clinical, community, and business environments.

Aspiring healthcare leaders should also consider programs with recognized credentials like a cahme accredited online mha programs list, which ensures high educational standards and broad career prospects in health administration.

Best Scientists Citing Giovanni Martinelli

Trending Scientists